Product Details
Product Name:
SCAL-255 |
CAS No.:
2798953-61-2 |
Supply Ability:
10g |
Release date:
2025/04/30 |
Product Introduction
Bioactivity
Name | SCAL-255 |
Description | SCAL-255 is a mitochondrial complex I (CI) inhibitor, exhibiting potent inhibition with an IC50 of 1.14 μM. It impedes mitochondrial function by blocking oxygen consumption rate (OCR), inducing reactive oxygen species (ROS) production, and diminishing mitochondrial membrane potential (MMP). Furthermore, SCAL-255 significantly hampers the proliferation of cancer cells reliant on oxidative phosphorylation (OXPHOS) [1]. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Keywords | MitochondrialMetabolism | Mitochondrial Metabolism |
Inhibitors Related | Imeglimin hydrochloride | Rotenone | α-Lipoic Acid | Tricarballylic acid | Boscalid | α-Lipoic Acid | (-)-Epigallocatechin Gallate | Lipoic acid | Daidzin | CCCP | D-Histidine | Nerol |
Company Profile Introduction
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds.
170+ Compound Libraries, 10000+ Noval Small Molecucles,16000+ Nature Compounds
TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.
You may like
-
CAS:186293-38-9
$2580.00 / 50mg
-
CAS:2798953-78-1
$2500.00 / 100mg
-
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$88.00/2mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2025-04-29 |